Hyperbilirubinemia in a Patient Receiving Alectinib for Anaplastic Lymphoma Kinase Positive Non-Small-Cell Lung Cancer: A Histological Features
This is the first report of alectinib-induced hyperbilirubinemia which was confirmed by liver histopathology and successfully relieved by ALSS treatment and drug discontinuation.
Authors
- Donglin Yin
- Yu-Jie Bao (ORCID: https://orcid.org/0000-0002-0674-4225)
- Lei Yan (ORCID: https://orcid.org/0000-0003-2596-6840)
- Xiaoling Yuan
- Jie Xu (ORCID: https://orcid.org/0000-0002-2441-1221)
- Qian Zhang (ORCID: https://orcid.org/0000-0002-9597-5032)
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Ninth People's Hospital (CN)
Publication Details
- Journal
- OncoTargets and Therapy
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/ott.s486860
- Citations
- 2
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.84